The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

Background. Identification of predictive molecular markers of triple-negative breast cancer (TNBC) will enable the evaluation of the efficacy of neoadjuvant chemotherapy (NACT) and define optimum approaches for the prognosis of the disease course in TNBC patients.The aim of the study was to examine...

Full description

Bibliographic Details
Main Authors: N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2020-04-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
triple-negative breast cancer
neoadjuvant chemotherapy
epidermal growth factor receptor (egfr)
gene polymorphisms
Online Access:https://bulletin.tomsk.ru/jour/article/view/2675

Internet

https://bulletin.tomsk.ru/jour/article/view/2675

Similar Items